The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.

Organ transplantation is a surgical procedure performed in case of organ failure. Usually, organ transplantation is conducted for organs such as the heart, liver, and kidney; however, with rising cases of chronic diseases, transplantation is needed for other organs such as lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all organ donations in the EU in 2019 and 6% of worldwide donations. Australia's organ donor rate has improved in recent years, rising to 21.8 donors per million population in 2019.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Autotransfusion Devices Market: Strategic Insights

Autotransfusion Devices Market

• 
  CAGR (2021 - 2028)

  4.2%
• Market Size 2021
  US$ 1 Billion
• Market Size 2028
  US$ 1.33 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Medtronic
• Fresenius SE & Co. KGaA
• Teleflex Incorporated
• BD
• Zimmer Biomet
• Braile Biomedica
• Haemonetics Corporation
• SARSTEDT AG and Co. KG
• LivaNova PLC

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Product and Accessories

Application

• Cardiac Surgeries
• Orthopedic Surgeries
• Organ Transplantation
• Trauma Procedures
• Others

End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the figure of "Donation Physicians" - intensive care doctors who are responsible for organ donation. According to the World Transplant Registry, China had 5,818 donors in 2019, or 4.1 per million population and India had 715 donors or 0.5 per million population in 2019. On the other hand, Russia had a slightly higher rate of 5.1 donors per million people. The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific. Countries are progressing in terms of providing better and advanced medical treatments. Thus, the rising need for organ transplantation is among the key factors driving the demand for transplant diagnostics such as autotransfusion devices.

The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.

Market Insights
Technological Developments in Autotransfusion Devices

Autotransfusion devices are usually deployed during long-hour surgeries, such as kidney transplantation, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up the blood loss with new blood, especially in case of rare blood groups. Owing to the ample demand, the key players in the autotransfusion devices market offer advanced and fully automated autotransfusion devices that reduce human interventions. For instance, in April 2021, LivaNova PLC's B-Capta has been approved by the US Food and Drug Administration. During complex paediatric and adult cardiopulmonary bypass surgeries, this device aids in the rapid and accurate monitoring of venous and blood gas parameters. Similarly, in April 2019, BD launched their BD BACTEC quality control media worldwide to help identify contaminated platelet units during transfusions.

Moreover, many companies employed strategic activities such as acquisitions, partnership and others to capture the market. For instance, Medtronics acquired AV Medical Technologies, in October 2019. In December 2019, Getinge purchased Applikon Biotechnology, a global leader in the development and supply of innovative bioreactor systems from the laboratory to the industrial scale. Thus, such advancements are likely to bring new trends in the autotransfusion devices market in the coming years.

Application–Based Insights

Based on application, the autotransfusion devices market is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period.

The autotransfusion devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio globally and meet the growing demand. The developments by the companies in the autotransfusion devices market have been characterized as organic and inorganic developments. Various companies are focusing on organic strategies, such as product launch and expansion. Inorganic growth strategies witnessed in the autotransfusion devices market were partnerships and collaborations. These growth strategies have aided the autotransfusion devices market players in the expansion of their businesses and enhanced their geographic presence. Additionally, growth strategies such as acquisitions and partnerships helped in strengthening their customer base and increasing the product portfolio. The companies have maximized their growth with several inorganic strategies to enhance the autotransfusion devices market value and position in the autotransfusion devices market. Organic developments hold 66.67% of the total strategic developments in the autotransfusion devices market. Whereas inorganic strategies account for 33.33% of the growth of the companies.

The autotransfusion devices market has been segmented as follows:

The autotransfusion devices market is segmented based on type, application, and end user. Based on type, the autotransfusion devices market is bifurcated into products and accessories. The autotransfusion devices market, based on application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others.

The autotransfusion devices market, based on end user, is divided into hospitals, specialty clinics, and ambulatory surgical centers.

Autotransfusion Devices Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Company Profiles in Autotransfusion Devices Market

• BD
• Braile Biomedica
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• LivaNova PLC
• Medtronic
• Redax S.p.A.
• SARSTEDT AG and Co. KG
• Teleflex Incorporated
• Zimmer Biomet